Acid addition salt of afatinib and its crystal form, its preparation method and pharmaceutical composition
A technology of afatinib and tinib ethanedisulfonate, applied in the directions of drug combination, carboxylate preparation, sulfonate preparation, etc., can solve the problem of affecting the uniformity of preparations, reducing the content of pharmaceutical active substances, and limiting hygroscopicity and other problems, to achieve the effect of reducing the risk of curative effect decline and safety risk, improving the uniformity of the preparation, and having a good crystal morphology.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0321] Preparation Example 1 Preparation of prior art crystal form of afatinib dimaleate
[0322] Take 100mg of afatinib free base and add 1.5mL of ethanol to stir to dissolve, heat to 70℃, take 50mg of maleic acid and add 0.4mL of ethanol to stir to dissolve, slowly add the ethanol solution of maleic acid to the free base of afatinib In the ethanol solution, stir, after the solid precipitated, the reaction solution was cooled to room temperature, stirred at room temperature for 2-3 hours, filtered, and dried under vacuum at 40°C overnight to obtain afatinib dimaleate.
[0323] XRPD analysis such as figure 2 As shown, the display is consistent with the prior art crystal form of afatinib dimaleate disclosed in CN1867564B.
[0324] TGA map such as image 3 As shown, the decomposition temperature of the salt is 164.1°C.
[0325] The DSC spectrum is as Figure 4 As shown, the melting point of the salt is 166.2°C.
[0326] DVS isotherm adsorption curve as Figure 5 As shown, the salt sho...
Example Embodiment
[0327] Example 1 Preparation of afatinib ethanedisulfonate
[0328] Take 50mg of afatinib free base and add 1mL of ethyl acetate and stir to dissolve, add 19.6mg of ethanedisulfonic acid to 2mL of ethyl acetate and stir to dissolve, slowly drop the ethyl acetate solution of ethanedisulfonic acid until the afatinib is free A slurry was formed in the ethyl acetate solution of the base, stirred and reacted overnight at room temperature, a solid precipitated out, and was spin-dried under vacuum at 40° C. to obtain 68 mg of afatinib edisulfonate with a yield of 97.7%.
Example Embodiment
[0329] Example 2 Preparation of E1 crystal form of afatinib ethanedisulfonate
[0330] Take 50mg of afatinib free base and add 1mL of acetonitrile and stir to dissolve, take 19.6mg of ethanedisulfonic acid and add 2mL of acetonitrile and stir to dissolve, slowly drop the acetonitrile solution of ethanedisulfonic acid into the acetonitrile solution of afatinib free base to form The slurry was stirred and reacted overnight at room temperature to precipitate solids, filtered, and dried overnight in vacuum at 40°C to obtain 62 mg of E1 crystal form afatinib edisulphonate with a yield of 89%.
PUM
Property | Measurement | Unit |
---|---|---|
Decomposition temperature | aaaaa | aaaaa |
Melting point | aaaaa | aaaaa |
Decomposition temperature | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap